In the News

491 News Items found
DLP+ in action
In the Lab
Developed by scientists at MSK and the University of British Columbia/BC Cancer, the platform provides the deepest look yet into tumor evolution.
Tiffany A. Traina, Vice Chair of the Department of Medicine at Memorial Sloan Kettering
Meet Tiffany Traina, a breast medical oncologist and the Vice Chair of the Department of Medicine at Memorial Sloan Kettering.
A liquid being pipetted into a well plate.
Fifteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 13, 2026, as part of Memorial Sloan Kettering’s 47th annual academic convocation.
Physician-scientist Alex Kentsis
In the Lab
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
Roberta Zappasodi, Taha Merghoub, and Jedd Wolchok. Photo credit: Flynn Larsen for Ludwig Cancer Research
More sugar available for immune cells could mean better immune responses against cancer.
Dr. Diane Reidy-Lagunes sits at a desk with a microphone
Thank you to our donor community. Your commitment to supporting Memorial Sloan Kettering Cancer Center (MSK) is essential to advancing our mission.
Illustration of DNA with green wrench making adjustments to a nut on the double helix.
Science Byte
A study reveals unexpected insights into how cells prepare broken DNA strands to be rejoined, preventing mutations that can cause cancer.
Selwyn M. Vickers, MD, FACS
In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.
A researcher working in an MSK lab
MSK Research Highlights, December 16, 2025
New MSK research finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will turn into multiple myeloma; develops a data-driven approach that could catch lymphedema earlier; and shows that nurse-led palliative care delivered by phone could serve as a scalable model.
This screenshot from a video shows an 11-day-old mouse embryo with its internal organs highlighted in fluorescence.
Quantum Leap
MSK investigators are leading the way with approaches so bold they are like the difference between "a snapshot and a movie."